Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation

ACS Medicinal Chemistry Letters

Volumn 2, Issue 3, 2011, Pages 230-233

  Baiocco, Paola ^a   Ilari, Andrea ^a   Ceci, Pierpaolo ^a   Orsini, Stefania ^b   Gramiccia, Marina ^b   Di Muccio, Trentina ^b   Colotti, Gianni ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

drug delivery; Leishmania; nanoparticles; silver; Trypanothione reductase

Indexed keywords

ANTIMONY; FERRITIN; SILVER; SILVER NANOPARTICLE; TRYPANOTHIONE REDUCTASE;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG SOLUBILITY; ENZYME ACTIVITY; IC 50; IN VITRO STUDY; LEISHMANIA INFANTUM; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

EUKARYOTA; LEISHMANIA INFANTUM;

EID: 79952639221     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml1002629     Document Type: Article

References (20)

1. Desjeux, P. Leishmaniasis. Public health aspects and control Clin. Dermatol. 1996, 14, 417-423 (Pubitemid 26327735)
2. Croft, S. L.; Sundar, S.; Fairlamb, A. H. Drug resistance in leishmaniasis Clin. Microbiol. Rev. 2006, 19, 111-126 (Pubitemid 43157649)
3. Irigoin, F.; Cibils, L.; Comini, M. A.; Wilkinson, S. R.; Flohé, L.; Radi, R. Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification Free Radical Biol. Med. 2008, 45, 733-742
4. Krauth-Siegel, R. L.; Comini, M. A. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism Biochim. Biophys. Acta 2008, 1780, 1236-1248
5. Fairlamb, A. H.; Blackburn, P.; Ulrich, P.; Chait, B. T.; Cerami, A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids Science 1985, 227, 1485-1487 (Pubitemid 15146992)
6. Denton, H.; McGregor, J. C.; Coombs, G. H. Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1 Biochem. J. 2004, 381, 405-412 (Pubitemid 38969684)
7. Cunningham, M. L.; Fairlamb, A. H. Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials Eur. J. Biochem. 1995, 230, 460-468
8. Baiocco, P.; Colotti, G.; Franceschini, S.; Ilari, A. Molecular basis of antimony treatment in leishmaniasis J. Med. Chem. 2009, 52, 2603-2612
9. Lowe, G.; Droz, A. S.; Vilaivan, T.; Weaver, G. W.; Tweedale, L.; Pratt, J. M.; Rock, P.; Yardley, V.; Croft, S. L. Cytotoxicity of (2,2′:6′, 2′′-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei J. Med. Chem. 1999, 42, 999-1006 (Pubitemid 29153429)
10. Vieites, M.; Smircich, P.; Buggeri, L.; Marchán, E.; Gómez-Barrio, A.; Navarro, M.; Garat, B.; Gambino, D. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action J. Inorg. Biochem. 2009, 103, 1300-1306
11. Navarro, M.; Cisneros-Fajardo, E. J.; Marchan, E. New silver polypyridyl complexes: synthesis, characterization and biological activity on Leishmania mexicana Arzneimittelforschung 2006, 56, 600-604 (Pubitemid 44358652)
12. Liau, S. Y.; Read, D. C.; Pugh, W. J.; Furr, J. R.; Russell, A. D. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions Lett. Appl. Microbiol. 1997, 25, 279-283 (Pubitemid 27438351)
13. Kasyutich, O.; Ilari, A.; Fiorillo, A.; Tatchev, D.; Hoell, A.; Ceci, P. Silver ion incorporation and nanoparticle formation inside the cavity of Pyrococcus furiosus ferritin: structural and size-distribution analyses J. Am. Chem. Soc. 2010, 132, 3621-3627
14. Kosuge, H.; Terashima, M.; Uchida, M.; Sherlock, S.; Tsao, P. S.; Young, M. J.; Douglas, T.; Dai, H.; McConnell, M. V. 7 T MRI of macrophages in mouse carotid atherosclerosis using novel nanoparticle platforms J. Cardiovasc. Magn. Reson. 2009, 11 (Suppl. 1) 151
15. Uchida, M.; Terashima, M.; Cunningham, C. H.; Suzuki, Y.; Willits, D. A.; Willis, A. F.; Yang, P. C.; Tsao, P. S.; McConnell, M. V.; Young, M. J.; Douglas, T. A human ferritin iron oxide nano-composite magnetic resonance contrast agent Magn. Reson. Med. 2008, 60, 1073-1081
16. Rai, M.; Yadav, A.; Gade, A. Silver nanoparticles as a new generation of antimicrobials Biotechnol. Adv. 2009, 27, 76-83
17. Sereno, D.; Lemesre, J. L. Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro Parasitol. Res. 1997, 83, 401-403 (Pubitemid 27198478)
18. Pujals, G.; Suñé-Negre, J. M.; Pérez, P.; García, E.; Portus, M.; Tico, J. R.; Miñarro, M.; Carrió, J. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum Parasitology Res. 2008, 102, 1243-1247
19. DeLano, W. L. The PyMOL Molecular Graphics System; DeLano Scientific: San Carlos, CA, 2002.
20. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr., D: Biol. Crystallogr. 2004, 60, 2126-2132 (Pubitemid 41742764)